Can Investor Day Turn Avon Products Around?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Can Investor Day Turn Avon Products Around?

© Thinkstock

Avon Products Inc. (NYSE: AVP) hosted its 2016 investor day Thursday, and so far it appears investors are liking everything the company has put out. The key point from this investor day was Avon reaffirming its full-year 2015 outlook mentioned in the third-quarter earnings call.

In 2015, Avon made progress against its full-year objectives in line with its previously stated outlook. Including the results of North America, Avon’s full-year 2015 constant-dollar revenue is expected to be flat as compared with the prior year.

As announced in mid-December, Avon intends to separate its North American business. Avon expects full-year 2015 results to include (excluding the results of North America):

  • Total revenue of roughly $6 billion
  • Constant dollar revenue growth of 2% (decline of 19% in reported dollars)
  • Growth in active representatives of 1%

Jim Scully, chief operating officer and chief financial officer, commented:

Our full-year performance is expected to be in-line with our most recent outlook. We will provide full details of our fourth-quarter and full-year 2015 performance at our earnings call on February 11th, which will include the reporting of our North American business as discontinued operations caused by its anticipated separation from Avon.

[ims_survey]
So far in 2016, Avon has drastically underperformed the market, with the stock down 40% year to date. Over the past 52 weeks, this number does not get any better, as shares are down 66% in this time.

Shares of Avon were trading up 12% at $2.73 on Thursday, with a consensus analyst price target of $4.65 and a 52-week trading range of $2.21 to $9.47.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618